Eudesmin
Eudesmin ((-) -Eudesmin) impairs adipogenic differentiation via inhibition of S6K1 signaling pathway. Eudesmin possesses diverse therapeutic effects, including anti-tumor, anti-inflammatory, and anti-bacterial activities[1].
Product Specifications
CAS Number
526-06-7
Product Name Alternative
(-) -Eudesmin; Eudesmine; (-) -Eudesmine
UNSPSC
12352005
Hazard Statement
H302
Target
Ribosomal S6 Kinase (RSK)
Type
Natural Products
Related Pathways
MAPK/ERK Pathway
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Cancer; Infection; Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/eudesmin.html
Purity
99.96
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COC(C=C(C=C1)[C@@]2([H])[C@@]3([H])[C@](CO2)([H])[C@@](C(C=C4)=CC(OC)=C4OC)([H])OC3)=C1OC
Molecular Formula
C22H26O6
Molecular Weight
386.44
Precautions
H302
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
P70S6K
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NFATc1 (NFATc-1, Nuclear Factor of Activated T-cells c1, NFATc 1) (FITC)
ILDR1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)